Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $3.5 million.

  • Trinity Biotech's Long-Term Deferred Tax rose 4732.03% to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year increase of 4732.03%. This contributed to the annual value of $3.6 million for FY2024, which is 7989.87% up from last year.
  • Latest data reveals that Trinity Biotech reported Long-Term Deferred Tax of $3.5 million as of Q2 2025, which was up 4732.03% from $3.6 million recorded in Q4 2024.
  • In the past 5 years, Trinity Biotech's Long-Term Deferred Tax ranged from a high of $4.6 million in Q2 2022 and a low of $694000.0 during Q3 2024
  • For the 5-year period, Trinity Biotech's Long-Term Deferred Tax averaged around $3.2 million, with its median value being $3.6 million (2021).
  • As far as peak fluctuations go, Trinity Biotech's Long-Term Deferred Tax tumbled by 7529.1% in 2023, and later skyrocketed by 11395.56% in 2024.
  • Over the past 5 years, Trinity Biotech's Long-Term Deferred Tax (Quarter) stood at $4.1 million in 2021, then increased by 2.85% to $4.2 million in 2022, then plummeted by 53.18% to $2.0 million in 2023, then soared by 79.9% to $3.6 million in 2024, then fell by 0.2% to $3.5 million in 2025.
  • Its Long-Term Deferred Tax stands at $3.5 million for Q2 2025, versus $3.6 million for Q4 2024 and $694000.0 for Q3 2024.